MAYO CLINIC FLORIDA

Mayo Clinic Florida specializes in advanced biomedical research and clinical innovation, with a primary focus on oncology and neurodegenerative diseases. Their core capabilities include the development of CAR-T therapies, postbiotic immune reprogramming to combat checkpoint inhibitor resistance in triple-negative breast cancer, and the optimization of combination therapies for RAS-mutated colorectal cancer. The organization also demonstrates deep technical expertise in Alzheimer’s disease research, specifically in mapping proteostasis, energy metabolism, and glymphatic function using human organ-on-chip models, as well as developing ultra-sensitive CSF detection methods for diagnostic monitoring. Additionally, they integrate cutting-edge technology into healthcare through the deployment of multimodal agentic virtual assistants. The organization works extensively with the Department of Health, primarily executing high-impact research grants. Their relationship with the agency is centered on advancing public health through the Florida Cancer Innovation Fund and the Ed and Ethel Moore Alzheimer’s Disease Research Program, focusing on emerging research trends and promising clinical practices.